Finally, the IGF2BP3 knockdown T24 cells or control group were injected under the skin of nude mice to establish an animal model to observe whether the expression of IGF2BP3 in animals affected the sensitivity of bladder cancer to cisplatin (Figure 4E). This evidence concerns the gene IGF2BP3 and urinary bladder cancer.